Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Clinical trial NCT00272181 · TERMINATED

Trial details

NCT number: NCT00272181
Sponsor: Sesen Bio, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck Carcinoma, Squamous Cell Neoplasms, Squamous Cell Head and Neck Neoplasms Mouth Neoplasms Head and Neck Cancer

Start date: 2006-01-01
Primary completion: 2007-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.